GlassScriptPhysician profile
Douglas Coslett
NPI 1578556924
$790.40
in general payments reported to CMS, 2019-2025
10 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Addiction Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $115).
See the full distribution for Addiction Medicine (Preventive Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $71.75 · 2021: $67.68 · 2022: $22.40 · 2023: $63.98 · 2024: $20.68 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $227.50 | 2019 | |
| Braeburn INC. | $216.93 | 2023-2025 | Brixadi |
| Alkermes, INC. | $117.65 | 2021-2023 | Vivitrol |
| Roche Diagnostics Corporation | $95.88 | 2019-2020 | |
| Daiichi Sankyo INC. | $40.53 | 2019-2020 | |
| Therapeuticsmd, INC. | $24.53 | 2020 | |
| Indivior INC. | $18.53 | 2023 | Sublocade |
| Bayer Healthcare Pharmaceuticals INC. | $17.68 | 2020 | |
| Amgen INC. | $17.39 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Coslett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.